Additive effect of combined spironolactone and phenobarbital treatment on hepatic bilirubin UDP-glucuronyltransferase.
Mottino
A D
AD
Instituto de Fisiología Experimental, Facultad de Ciencias, Bioquímicas y Farmacéuticas-U.N.R., Rosario, Argentina.
Guibert
E E
EE
Rodríguez Garay
E A
EA
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D004357:Drug Synergism; D004790:Enzyme Induction / Q000187:drug effects; D014453:Glucuronosyltransferase / Q000096:biosynthesis*; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology*; D009929:Organ Size / Q000187:drug effects; D010634:Phenobarbital / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D013148:Spironolactone / Q000494:pharmacology*
D013148:Spironolactone; D014453:Glucuronosyltransferase; D010634:Phenobarbital